A proposed overhaul of the National Cancer Institute’s clinical trials
system has created anxiety among gynecologic researchers who fear
projects in women’s cancer will be diminished in a scramble for funding
with more common malignancies.......
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.